These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1640957)

  • 1. Membranous nephropathy--still a treatment dilemma.
    Cameron JS
    N Engl J Med; 1992 Aug; 327(9):638-9. PubMed ID: 1640957
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
    Ponticelli C; Zucchelli P; Passerini P; Cesana B
    N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete remission of nephrotic syndrome after steroid-chlorambucil in a previous failed short-term steroidal treatment of a primary membranous nephropathy.
    Ardiles LG; Mezzano SA
    Clin Nephrol; 1996 Jun; 45(6):423. PubMed ID: 8793243
    [No Abstract]   [Full Text] [Related]  

  • 4. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome.
    Polenakovic M; Grcevska L; Dzikova S
    Prilozi; 2006 Dec; 27(2):5-12. PubMed ID: 17211287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Passerini P; Cagnoli L; Cesana B; Pozzi C; Pasquali S; Imbasciati E; Grassi C; Redaelli B
    N Engl J Med; 1989 Jan; 320(1):8-13. PubMed ID: 2642605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C; Passerini P; Salvadori M; Manno C; Viola BF; Pasquali S; Mandolfo S; Messa P
    Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
    Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
    Ponticelli C; Altieri P; Scolari F; Passerini P; Roccatello D; Cesana B; Melis P; Valzorio B; Sasdelli M; Pasquali S; Pozzi C; Piccoli G; Lupo A; Segagni S; Antonucci F; Dugo M; Minari M; Scalia A; Pedrini L; Pisano G; Grassi C; Farina M; Bellazzi R
    J Am Soc Nephrol; 1998 Mar; 9(3):444-50. PubMed ID: 9513907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Grassi C; Limido D; Pasquali S; Passerini P; Volpini T; Locatelli F
    Proc Eur Dial Transplant Assoc; 1983; 19():717-23. PubMed ID: 6348763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membranous allograft nephropathy. Remission of nephrotic syndrome with pulsed methylprednisolone and high-dose alternate-day steroids.
    Johnston PA; Goode NP; Aparicio SR; Davison AM
    Transplantation; 1993 Jan; 55(1):214-6. PubMed ID: 8420053
    [No Abstract]   [Full Text] [Related]  

  • 11. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
    Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Passerini P; Grassi C; Limido D; Pasquali S; Volpini T
    N Engl J Med; 1984 Apr; 310(15):946-50. PubMed ID: 6366560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Controlled study of treatment of steroids and chlorambucil, in alternate months, for membranous nephropathy and focal glomerulosclerosis. Preliminary evaluation of the results].
    Imbasciati E; Cagnoli L; Case N; Pasquali S; Di Filippo G; Limido D; Cornalba L; Volpini T; Pozzi C; Zuccelli P; Ponticelli C
    Minerva Nefrol; 1980; 27(4):571-5. PubMed ID: 7019771
    [No Abstract]   [Full Text] [Related]  

  • 14. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
    Reichert LJ; Huysmans FT; Assmann K; Koene RA; Wetzels JF
    Ann Intern Med; 1994 Sep; 121(5):328-33. PubMed ID: 8042821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membranous nephropathy associated with acute myeloid leukemia.
    Sahiner S; Ayli MD; Yüksel C; Oneç K; Abayli E
    Transplant Proc; 2004 Nov; 36(9):2618-9. PubMed ID: 15621104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term outcome of nephrotic syndrome due to primary membranous nephropathy].
    Fujimoto S; Yamamoto Y; Wakisaka O; Hisanaga S; Miyata J; Tanaka K
    Nihon Jinzo Gakkai Shi; 1988 Jun; 30(6):687-93. PubMed ID: 3172567
    [No Abstract]   [Full Text] [Related]  

  • 17. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
    Ponticelli C; Passerini P
    Clin Nephrol; 1991; 35 Suppl 1():S16-21. PubMed ID: 1860261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy.
    Ponticelli C; Zucchelli P; Passerini P; Cesana B; Locatelli F; Pasquali S; Sasdelli M; Redaelli B; Grassi C; Pozzi C
    Kidney Int; 1995 Nov; 48(5):1600-4. PubMed ID: 8544420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
    Knotková V; Nĕmecek K; Tarayeva IE; Krasnova TN
    Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The advantages of immunosuppressive therapy in renal disease.
    Zucchelli P
    Ann Med Interne (Paris); 1988; 139(2):108-11. PubMed ID: 3293499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.